increased metastatic potential_Tg(MMTV-ERBB2)5Erick/?

http://metadb.riken.jp/0001272FVBNTgMMTVERBB25ErickTgMMTVERBB25ErickTgMMTVERBB25Erick

increased metastatic potential_Tg(MMTV-ERBB2)5Erick/?

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 5, Sharon Erickson
  http://metadb.riken.jp/db/mgi_rdf/MGI:5527315

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(MMTV-ERBB2)5Erick/?

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(MMTV-ERBB2)5Erick

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• FVB/N-Tg(MMTV-ERBB2)5Erick

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased metastatic potential
  http://purl.obolibrary.org/obo/MP_0001272

文献

http://purl.org/net/cito/citesAsAuthority

• David. Finkle, et.al., HER2-targeted therapy reduces incidence and progression of midlife mammary tumors in female murine mammary tumor virus huHER2-transgenic mice., Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, 10
  http://rdf.ncbi.nlm.nih.gov/pubmed/15073130